Novacyt S.A.
Novacyt S.A. NVYTF Peers
See (NVYTF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NVYTF | $0.54 | N/A | 38M | -0.73 | -$0.74 | N/A |
| SMMNY | $26.53 | +0.25% | 119B | 25.03 | $1.06 | +0.98% |
| SEMHF | $52.88 | +1.11% | 59.3B | 25.06 | $2.11 | +2.14% |
| RYLPF | $22.41 | N/A | 20.7B | 74.71 | $0.30 | +4.24% |
| SONVY | $62.33 | +0.71% | 18.6B | 28.33 | $2.20 | +1.53% |
| SONVF | $298.00 | N/A | 17.8B | 27.09 | $11.00 | +1.96% |
| SNNUF | $15.38 | +2.53% | 13.5B | 32.72 | $0.47 | +2.44% |
| CHEOF | $182.46 | N/A | 11.9B | 50.26 | $3.63 | +1.52% |
| CHEOY | $87.07 | -1.14% | 11.4B | 47.84 | $1.82 | +1.61% |
| WILYY | $20.71 | +4.79% | 8.8B | 20.50 | $1.01 | N/A |
Stock Comparison
NVYTF vs SMMNY Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, SMMNY has a market cap of 119B. Regarding current trading prices, NVYTF is priced at $0.54, while SMMNY trades at $26.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas SMMNY's P/E ratio is 25.03. In terms of profitability, NVYTF's ROE is -0.23%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, NVYTF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs SEMHF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, SEMHF has a market cap of 59.3B. Regarding current trading prices, NVYTF is priced at $0.54, while SEMHF trades at $52.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas SEMHF's P/E ratio is 25.06. In terms of profitability, NVYTF's ROE is -0.23%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, NVYTF is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs RYLPF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, RYLPF has a market cap of 20.7B. Regarding current trading prices, NVYTF is priced at $0.54, while RYLPF trades at $22.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas RYLPF's P/E ratio is 74.71. In terms of profitability, NVYTF's ROE is -0.23%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, NVYTF is less volatile compared to RYLPF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs SONVY Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, SONVY has a market cap of 18.6B. Regarding current trading prices, NVYTF is priced at $0.54, while SONVY trades at $62.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas SONVY's P/E ratio is 28.33. In terms of profitability, NVYTF's ROE is -0.23%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, NVYTF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs SONVF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, SONVF has a market cap of 17.8B. Regarding current trading prices, NVYTF is priced at $0.54, while SONVF trades at $298.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas SONVF's P/E ratio is 27.09. In terms of profitability, NVYTF's ROE is -0.23%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, NVYTF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs SNNUF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, SNNUF has a market cap of 13.5B. Regarding current trading prices, NVYTF is priced at $0.54, while SNNUF trades at $15.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas SNNUF's P/E ratio is 32.72. In terms of profitability, NVYTF's ROE is -0.23%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, NVYTF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs CHEOF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, CHEOF has a market cap of 11.9B. Regarding current trading prices, NVYTF is priced at $0.54, while CHEOF trades at $182.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas CHEOF's P/E ratio is 50.26. In terms of profitability, NVYTF's ROE is -0.23%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, NVYTF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs CHEOY Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, CHEOY has a market cap of 11.4B. Regarding current trading prices, NVYTF is priced at $0.54, while CHEOY trades at $87.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas CHEOY's P/E ratio is 47.84. In terms of profitability, NVYTF's ROE is -0.23%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, NVYTF is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs WILYY Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, WILYY has a market cap of 8.8B. Regarding current trading prices, NVYTF is priced at $0.54, while WILYY trades at $20.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas WILYY's P/E ratio is 20.50. In terms of profitability, NVYTF's ROE is -0.23%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, NVYTF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs WILLF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, WILLF has a market cap of 7.9B. Regarding current trading prices, NVYTF is priced at $0.54, while WILLF trades at $38.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas WILLF's P/E ratio is 18.83. In terms of profitability, NVYTF's ROE is -0.23%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, NVYTF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs GNGBF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, GNGBF has a market cap of 5.4B. Regarding current trading prices, NVYTF is priced at $0.54, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas GNGBF's P/E ratio is 37.70. In terms of profitability, NVYTF's ROE is -0.23%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, NVYTF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs GNGBY Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, GNGBY has a market cap of 5.4B. Regarding current trading prices, NVYTF is priced at $0.54, while GNGBY trades at $19.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas GNGBY's P/E ratio is 34.95. In terms of profitability, NVYTF's ROE is -0.23%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, NVYTF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs AMBFF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, AMBFF has a market cap of 4B. Regarding current trading prices, NVYTF is priced at $0.54, while AMBFF trades at $15.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas AMBFF's P/E ratio is 72.21. In terms of profitability, NVYTF's ROE is -0.23%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, NVYTF is less volatile compared to AMBFF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs AMBBY Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, AMBBY has a market cap of 4B. Regarding current trading prices, NVYTF is priced at $0.54, while AMBBY trades at $15.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas AMBBY's P/E ratio is 71.96. In terms of profitability, NVYTF's ROE is -0.23%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, NVYTF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs NHNKY Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, NHNKY has a market cap of 4B. Regarding current trading prices, NVYTF is priced at $0.54, while NHNKY trades at $12.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas NHNKY's P/E ratio is 20.59. In terms of profitability, NVYTF's ROE is -0.23%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, NVYTF is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs NHNKF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, NVYTF is priced at $0.54, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, NVYTF's ROE is -0.23%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, NVYTF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs VTRLY Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, VTRLY has a market cap of 2.2B. Regarding current trading prices, NVYTF is priced at $0.54, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas VTRLY's P/E ratio is 42.03. In terms of profitability, NVYTF's ROE is -0.23%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, NVYTF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs GNNDY Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, GNNDY has a market cap of 2.1B. Regarding current trading prices, NVYTF is priced at $0.54, while GNNDY trades at $43.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas GNNDY's P/E ratio is 17.20. In terms of profitability, NVYTF's ROE is -0.23%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, NVYTF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs GGNDF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, NVYTF is priced at $0.54, while GGNDF trades at $14.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas GGNDF's P/E ratio is 16.91. In terms of profitability, NVYTF's ROE is -0.23%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, NVYTF is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs STSEY Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, NVYTF is priced at $0.54, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas STSEY's P/E ratio is 39.41. In terms of profitability, NVYTF's ROE is -0.23%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, NVYTF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs OSSFF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, OSSFF has a market cap of 1.8B. Regarding current trading prices, NVYTF is priced at $0.54, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, NVYTF's ROE is -0.23%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, NVYTF is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs DWRKF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, NVYTF is priced at $0.54, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, NVYTF's ROE is -0.23%, compared to DWRKF's ROE of N/A. Regarding short-term risk, NVYTF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs MCRPF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, MCRPF has a market cap of 1.7B. Regarding current trading prices, NVYTF is priced at $0.54, while MCRPF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas MCRPF's P/E ratio is -7.82. In terms of profitability, NVYTF's ROE is -0.23%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, NVYTF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs OSSUY Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, NVYTF is priced at $0.54, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, NVYTF's ROE is -0.23%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, NVYTF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs MEDGF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, NVYTF is priced at $0.54, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, NVYTF's ROE is -0.23%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, NVYTF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs DRWKF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, DRWKF has a market cap of 1.3B. Regarding current trading prices, NVYTF is priced at $0.54, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas DRWKF's P/E ratio is 8.97. In terms of profitability, NVYTF's ROE is -0.23%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, NVYTF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs DGWPF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, DGWPF has a market cap of 1.2B. Regarding current trading prices, NVYTF is priced at $0.54, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas DGWPF's P/E ratio is 8.18. In terms of profitability, NVYTF's ROE is -0.23%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, NVYTF is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs XVIPF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, XVIPF has a market cap of 1B. Regarding current trading prices, NVYTF is priced at $0.54, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas XVIPF's P/E ratio is 73.11. In terms of profitability, NVYTF's ROE is -0.23%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, NVYTF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs LFTSF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, NVYTF is priced at $0.54, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, NVYTF's ROE is -0.23%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, NVYTF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs ELEAF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, ELEAF has a market cap of 832.7M. Regarding current trading prices, NVYTF is priced at $0.54, while ELEAF trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas ELEAF's P/E ratio is 11.94. In terms of profitability, NVYTF's ROE is -0.23%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, NVYTF is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs MDRSF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, MDRSF has a market cap of 828.1M. Regarding current trading prices, NVYTF is priced at $0.54, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, NVYTF's ROE is -0.23%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, NVYTF is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs CALZF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, CALZF has a market cap of 559.6M. Regarding current trading prices, NVYTF is priced at $0.54, while CALZF trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas CALZF's P/E ratio is 81.00. In terms of profitability, NVYTF's ROE is -0.23%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, NVYTF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs AVMR Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, NVYTF is priced at $0.54, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas AVMR's P/E ratio is -18.34. In terms of profitability, NVYTF's ROE is -0.23%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, NVYTF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs CLVSF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, CLVSF has a market cap of 459.8M. Regarding current trading prices, NVYTF is priced at $0.54, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, NVYTF's ROE is -0.23%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, NVYTF is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs IOBCF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, IOBCF has a market cap of 404.3M. Regarding current trading prices, NVYTF is priced at $0.54, while IOBCF trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas IOBCF's P/E ratio is 38.33. In terms of profitability, NVYTF's ROE is -0.23%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, NVYTF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs HYBT Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, NVYTF is priced at $0.54, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas HYBT's P/E ratio is N/A. In terms of profitability, NVYTF's ROE is -0.23%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, NVYTF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs EAPIF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, EAPIF has a market cap of 290.4M. Regarding current trading prices, NVYTF is priced at $0.54, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas EAPIF's P/E ratio is -1.94. In terms of profitability, NVYTF's ROE is -0.23%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, NVYTF is less volatile compared to EAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs CLLKF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, CLLKF has a market cap of 264.5M. Regarding current trading prices, NVYTF is priced at $0.54, while CLLKF trades at $3.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas CLLKF's P/E ratio is -8.51. In terms of profitability, NVYTF's ROE is -0.23%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, NVYTF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs CSSPF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, CSSPF has a market cap of 263.4M. Regarding current trading prices, NVYTF is priced at $0.54, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, NVYTF's ROE is -0.23%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, NVYTF is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs CYBQY Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, CYBQY has a market cap of 260.8M. Regarding current trading prices, NVYTF is priced at $0.54, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas CYBQY's P/E ratio is -61.00. In terms of profitability, NVYTF's ROE is -0.23%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, NVYTF is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs HTLZF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, NVYTF is priced at $0.54, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, NVYTF's ROE is -0.23%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, NVYTF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs BCCOY Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, BCCOY has a market cap of 221M. Regarding current trading prices, NVYTF is priced at $0.54, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, NVYTF's ROE is -0.23%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, NVYTF is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs IMPZY Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, IMPZY has a market cap of 199.9M. Regarding current trading prices, NVYTF is priced at $0.54, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, NVYTF's ROE is -0.23%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, NVYTF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs CYBQF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, CYBQF has a market cap of 162.8M. Regarding current trading prices, NVYTF is priced at $0.54, while CYBQF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas CYBQF's P/E ratio is -61.00. In terms of profitability, NVYTF's ROE is -0.23%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, NVYTF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs BRNHF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, BRNHF has a market cap of 161.8M. Regarding current trading prices, NVYTF is priced at $0.54, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, NVYTF's ROE is -0.23%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, NVYTF is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs EKDHF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, EKDHF has a market cap of 161.7M. Regarding current trading prices, NVYTF is priced at $0.54, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, NVYTF's ROE is -0.23%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, NVYTF is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs PXMBF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, PXMBF has a market cap of 160.8M. Regarding current trading prices, NVYTF is priced at $0.54, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, NVYTF's ROE is -0.23%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, NVYTF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs JMDMF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, JMDMF has a market cap of 157.9M. Regarding current trading prices, NVYTF is priced at $0.54, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, NVYTF's ROE is -0.23%, compared to JMDMF's ROE of N/A. Regarding short-term risk, NVYTF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs AVHHL Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, AVHHL has a market cap of 156.8M. Regarding current trading prices, NVYTF is priced at $0.54, while AVHHL trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas AVHHL's P/E ratio is -2.61. In terms of profitability, NVYTF's ROE is -0.23%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, NVYTF is less volatile compared to AVHHL. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs BRSYF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, BRSYF has a market cap of 128.4M. Regarding current trading prices, NVYTF is priced at $0.54, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, NVYTF's ROE is -0.23%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, NVYTF is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs AMEUF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, NVYTF is priced at $0.54, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, NVYTF's ROE is -0.23%, compared to AMEUF's ROE of -5.13%. Regarding short-term risk, NVYTF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs VMTHF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, VMTHF has a market cap of 110M. Regarding current trading prices, NVYTF is priced at $0.54, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, NVYTF's ROE is -0.23%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, NVYTF is less volatile compared to VMTHF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs FDMDF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, FDMDF has a market cap of 106.1M. Regarding current trading prices, NVYTF is priced at $0.54, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, NVYTF's ROE is -0.23%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, NVYTF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs SOMNF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, SOMNF has a market cap of 92.1M. Regarding current trading prices, NVYTF is priced at $0.54, while SOMNF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas SOMNF's P/E ratio is -14.20. In terms of profitability, NVYTF's ROE is -0.23%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, NVYTF is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs RSHUF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, NVYTF is priced at $0.54, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, NVYTF's ROE is -0.23%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, NVYTF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs CKMTF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, NVYTF is priced at $0.54, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, NVYTF's ROE is -0.23%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, NVYTF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs DMTRF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, DMTRF has a market cap of 76.1M. Regarding current trading prices, NVYTF is priced at $0.54, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, NVYTF's ROE is -0.23%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, NVYTF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs SNZZF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, SNZZF has a market cap of 71.9M. Regarding current trading prices, NVYTF is priced at $0.54, while SNZZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas SNZZF's P/E ratio is -5.40. In terms of profitability, NVYTF's ROE is -0.23%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, NVYTF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs IPDQF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, IPDQF has a market cap of 68.1M. Regarding current trading prices, NVYTF is priced at $0.54, while IPDQF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas IPDQF's P/E ratio is -3.36. In terms of profitability, NVYTF's ROE is -0.23%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, NVYTF is less volatile compared to IPDQF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs RDGL Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, RDGL has a market cap of 60.3M. Regarding current trading prices, NVYTF is priced at $0.54, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas RDGL's P/E ratio is -13.29. In terms of profitability, NVYTF's ROE is -0.23%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, NVYTF is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs BLOZF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, BLOZF has a market cap of 53.5M. Regarding current trading prices, NVYTF is priced at $0.54, while BLOZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas BLOZF's P/E ratio is -23.25. In terms of profitability, NVYTF's ROE is -0.23%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, NVYTF is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs TLTFF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, TLTFF has a market cap of 34.6M. Regarding current trading prices, NVYTF is priced at $0.54, while TLTFF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas TLTFF's P/E ratio is -13.96. In terms of profitability, NVYTF's ROE is -0.23%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, NVYTF is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs ELXMF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, ELXMF has a market cap of 28.4M. Regarding current trading prices, NVYTF is priced at $0.54, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, NVYTF's ROE is -0.23%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, NVYTF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs KBBTF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, NVYTF is priced at $0.54, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, NVYTF's ROE is -0.23%, compared to KBBTF's ROE of N/A. Regarding short-term risk, NVYTF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs MKEAF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, MKEAF has a market cap of 23.9M. Regarding current trading prices, NVYTF is priced at $0.54, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, NVYTF's ROE is -0.23%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, NVYTF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs POSC Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, POSC has a market cap of 23.4M. Regarding current trading prices, NVYTF is priced at $0.54, while POSC trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas POSC's P/E ratio is 0.35. In terms of profitability, NVYTF's ROE is -0.23%, compared to POSC's ROE of +9.25%. Regarding short-term risk, NVYTF is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs EMITF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, EMITF has a market cap of 22.2M. Regarding current trading prices, NVYTF is priced at $0.54, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas EMITF's P/E ratio is -14.29. In terms of profitability, NVYTF's ROE is -0.23%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, NVYTF is less volatile compared to EMITF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs ASAPF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, ASAPF has a market cap of 17.6M. Regarding current trading prices, NVYTF is priced at $0.54, while ASAPF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas ASAPF's P/E ratio is -22.51. In terms of profitability, NVYTF's ROE is -0.23%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, NVYTF is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs DIZTF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, DIZTF has a market cap of 16.9M. Regarding current trading prices, NVYTF is priced at $0.54, while DIZTF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas DIZTF's P/E ratio is -10.50. In terms of profitability, NVYTF's ROE is -0.23%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, NVYTF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs MDXHF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, MDXHF has a market cap of 16.7M. Regarding current trading prices, NVYTF is priced at $0.54, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, NVYTF's ROE is -0.23%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, NVYTF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs PYNKF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, PYNKF has a market cap of 15.3M. Regarding current trading prices, NVYTF is priced at $0.54, while PYNKF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas PYNKF's P/E ratio is -0.78. In terms of profitability, NVYTF's ROE is -0.23%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, NVYTF is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs TMDIF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, NVYTF is priced at $0.54, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, NVYTF's ROE is -0.23%, compared to TMDIF's ROE of -1.38%. Regarding short-term risk, NVYTF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs PLLWF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, PLLWF has a market cap of 13.3M. Regarding current trading prices, NVYTF is priced at $0.54, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, NVYTF's ROE is -0.23%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, NVYTF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs GTHP Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, GTHP has a market cap of 13.1M. Regarding current trading prices, NVYTF is priced at $0.54, while GTHP trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas GTHP's P/E ratio is -3.33. In terms of profitability, NVYTF's ROE is -0.23%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, NVYTF is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs RMSL Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, RMSL has a market cap of 13.1M. Regarding current trading prices, NVYTF is priced at $0.54, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas RMSL's P/E ratio is 0.86. In terms of profitability, NVYTF's ROE is -0.23%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, NVYTF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs VPTDF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, VPTDF has a market cap of 13.1M. Regarding current trading prices, NVYTF is priced at $0.54, while VPTDF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas VPTDF's P/E ratio is -4.00. In terms of profitability, NVYTF's ROE is -0.23%, compared to VPTDF's ROE of +2.34%. Regarding short-term risk, NVYTF is more volatile compared to VPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs ALRTF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, ALRTF has a market cap of 12.7M. Regarding current trading prices, NVYTF is priced at $0.54, while ALRTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas ALRTF's P/E ratio is -0.67. In terms of profitability, NVYTF's ROE is -0.23%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, NVYTF is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs IMEXF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, IMEXF has a market cap of 11.8M. Regarding current trading prices, NVYTF is priced at $0.54, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas IMEXF's P/E ratio is N/A. In terms of profitability, NVYTF's ROE is -0.23%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, NVYTF is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs ATBPF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, NVYTF is priced at $0.54, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, NVYTF's ROE is -0.23%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, NVYTF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs LXXGF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, NVYTF is priced at $0.54, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, NVYTF's ROE is -0.23%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, NVYTF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs IRME Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, IRME has a market cap of 5.8M. Regarding current trading prices, NVYTF is priced at $0.54, while IRME trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas IRME's P/E ratio is -2.67. In terms of profitability, NVYTF's ROE is -0.23%, compared to IRME's ROE of +11.77%. Regarding short-term risk, NVYTF is more volatile compared to IRME. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs DTXMF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, DTXMF has a market cap of 5.7M. Regarding current trading prices, NVYTF is priced at $0.54, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, NVYTF's ROE is -0.23%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, NVYTF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs QLIS Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, NVYTF is priced at $0.54, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas QLIS's P/E ratio is 2.22. In terms of profitability, NVYTF's ROE is -0.23%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, NVYTF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs RHNMF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, NVYTF is priced at $0.54, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, NVYTF's ROE is -0.23%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, NVYTF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs FZMD Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, FZMD has a market cap of 5.2M. Regarding current trading prices, NVYTF is priced at $0.54, while FZMD trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas FZMD's P/E ratio is 1.40. In terms of profitability, NVYTF's ROE is -0.23%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, NVYTF is more volatile compared to FZMD. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs NUMD Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, NUMD has a market cap of 5M. Regarding current trading prices, NVYTF is priced at $0.54, while NUMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas NUMD's P/E ratio is 6.00. In terms of profitability, NVYTF's ROE is -0.23%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, NVYTF is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs TBRIF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, TBRIF has a market cap of 5M. Regarding current trading prices, NVYTF is priced at $0.54, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas TBRIF's P/E ratio is -1.10. In terms of profitability, NVYTF's ROE is -0.23%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, NVYTF is more volatile compared to TBRIF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs MICR Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, MICR has a market cap of 4.7M. Regarding current trading prices, NVYTF is priced at $0.54, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas MICR's P/E ratio is -3.47. In terms of profitability, NVYTF's ROE is -0.23%, compared to MICR's ROE of -0.25%. Regarding short-term risk, NVYTF is less volatile compared to MICR. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs LBLTF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, LBLTF has a market cap of 4.1M. Regarding current trading prices, NVYTF is priced at $0.54, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, NVYTF's ROE is -0.23%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, NVYTF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs VYCO Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, VYCO has a market cap of 3.9M. Regarding current trading prices, NVYTF is priced at $0.54, while VYCO trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas VYCO's P/E ratio is -11.80. In terms of profitability, NVYTF's ROE is -0.23%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, NVYTF is less volatile compared to VYCO. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs ADMT Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, ADMT has a market cap of 3.7M. Regarding current trading prices, NVYTF is priced at $0.54, while ADMT trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas ADMT's P/E ratio is -5.50. In terms of profitability, NVYTF's ROE is -0.23%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, NVYTF is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs BIEL Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, BIEL has a market cap of 3.6M. Regarding current trading prices, NVYTF is priced at $0.54, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas BIEL's P/E ratio is N/A. In terms of profitability, NVYTF's ROE is -0.23%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, NVYTF is more volatile compared to BIEL. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs LLBO Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, LLBO has a market cap of 3.5M. Regarding current trading prices, NVYTF is priced at $0.54, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas LLBO's P/E ratio is N/A. In terms of profitability, NVYTF's ROE is -0.23%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, NVYTF is more volatile compared to LLBO. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs VANIW Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, NVYTF is priced at $0.54, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas VANIW's P/E ratio is N/A. In terms of profitability, NVYTF's ROE is -0.23%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, NVYTF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs ESMC Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, ESMC has a market cap of 3.1M. Regarding current trading prices, NVYTF is priced at $0.54, while ESMC trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas ESMC's P/E ratio is 8.40. In terms of profitability, NVYTF's ROE is -0.23%, compared to ESMC's ROE of +0.00%. Regarding short-term risk, NVYTF is more volatile compared to ESMC. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs CYDX Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, CYDX has a market cap of 2.6M. Regarding current trading prices, NVYTF is priced at $0.54, while CYDX trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas CYDX's P/E ratio is 0.65. In terms of profitability, NVYTF's ROE is -0.23%, compared to CYDX's ROE of +0.17%. Regarding short-term risk, NVYTF is less volatile compared to CYDX. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs USAQ Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, USAQ has a market cap of 2.3M. Regarding current trading prices, NVYTF is priced at $0.54, while USAQ trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas USAQ's P/E ratio is -4.99. In terms of profitability, NVYTF's ROE is -0.23%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, NVYTF is less volatile compared to USAQ. This indicates potentially lower risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs PMEDF Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, PMEDF has a market cap of 2.2M. Regarding current trading prices, NVYTF is priced at $0.54, while PMEDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas PMEDF's P/E ratio is -1.47. In terms of profitability, NVYTF's ROE is -0.23%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, NVYTF is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.
NVYTF vs KLYG Comparison
NVYTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVYTF stands at 38M. In comparison, KLYG has a market cap of 1.8M. Regarding current trading prices, NVYTF is priced at $0.54, while KLYG trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVYTF currently has a P/E ratio of -0.73, whereas KLYG's P/E ratio is -13.89. In terms of profitability, NVYTF's ROE is -0.23%, compared to KLYG's ROE of -1.14%. Regarding short-term risk, NVYTF is more volatile compared to KLYG. This indicates potentially higher risk in terms of short-term price fluctuations for NVYTF.